Cemsidomide
- Generic Name
- Cemsidomide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H27N3O4
- CAS Number
- 2504235-67-8
- Unique Ingredient Identifier
- D86MF5H9WJ
- Associated Conditions
- -
- Associated Therapies
- -
Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- C4 Therapeutics, Inc.
- Target Recruit Count
- 224
- Registration Number
- NCT04756726
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Washington University School of St. Louis, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath